Tissue selective drug delivery utilizing carrier-mediated transport systems

被引:27
|
作者
Tsuji, A [1 ]
机构
[1] Kanazawa Univ, Fac Pharmaceut Sci, Dept Pharmacodynam, Kanazawa, Ishikawa 9200934, Japan
关键词
oligopeptide transporter; tumor cells; P-glycoprotein; beta-lactam antibiotics; HMG-CoA reductase inhibitors; new quinolones;
D O I
10.1016/S0168-3659(99)00043-7
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
This paper describes some successful examples of a tissue selective drug delivery by utilizing specialized transporter(s) expressed in the targeted tissue cells. These are as follows: (1) oral delivery via H+/oligopeptide transporter, rat or human Pept1, in the intestine for beta-lactam antibiotics and a newly synthesized dipeptide, L-dopa-L-phenylalanine; (2) tumor cell specific delivery via the newly discovered H+/oligopeptide transporter(s) expressed in human fibrosarcoma cell line MT-1080 for model oligopeptides, glycylsarcosine and carnosine; (3) oral and hepatic delivery via an H+/monocarboxylate transporter in the intestine and an organic anion transporter in the liver for HMG-CoA reductase inhibitor, pravastatin; and (4) lung selective delivery via some type of transporter and avoidance of transfer into the brain via P-glycoprotein at the blood-brain barrier for a new quinolone antibacterial, HSR-903. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:239 / 244
页数:6
相关论文
共 50 条